Search

everythinglearnresearchcommunity

for

Search:↓

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Diane 35 plus finasteride is more effective for treating hirsutism.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Flutamide reduces hair growth better but has more side effects.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Spironolactone plus finasteride reduces hirsutism more effectively.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Combining microsurgery with craniofacial reconstruction improves aesthetic results and reduces harm to the area where tissue is taken from.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Hair-tourniquet syndrome can cause serious toe injuries in infants but can be treated if found early.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.